CelluForce Launches CelluShield™ – Breakthrough Barrier Coating for Recyclable Flexible Packaging

22.9.2025 14:00:00 CEST | Business Wire | Press Release

CelluForce, the world leader in cellulose nanocrystals (CNC), today announced the launch of CelluShield™, a high-performance, bio-based barrier coating that enables recyclable flexible packaging without sacrificing shelf life or product protection.

Made from renewable cellulose and formulated as a water-based coating, CelluShield™ combines excellent oxygen and moisture barrier properties with compatibility for existing recycling streams. By enabling mono-material structures, the technology helps packaging manufacturers meet both performance demands and circular economy goals.

Developed in collaboration with FPInnovations, CelluShield™ reflects Canada's commitment to advancing innovative sustainable packaging solutions.

High-Performance Meets Sustainability

CelluShield™ protects food, pharmaceuticals, and other sensitive products without harmful chemicals or complex multilayer laminates. Key benefits include:

High barrier performance: OTR < 1 cc/m²·day and WVTR < 1 g/m²·day at 1 gsm coat weight.
Recyclable mono-material design: Enables PE, PP, or PET structures to meet EPR and EU PPWR requirements.
Safe & renewable: Bio-based, PFAS-free, VOC-free, chlorine-free, FDA and Health Canada compliant.

“Brand owners and converters no longer need to choose between performance and recyclability,” said Sébastien Corbeil, President and CEO of CelluForce. “CelluShield™ delivers a practical solution that protects products, reduces carbon footprint, and simplifies recycling while using a water-based technology that runs on existing equipment.”

Seamless Integration

Engineered for easy adoption on existing production lines, CelluShield™ is applied using reverse gravure coating and works with standard lamination for PE, PP, and PET films. It is available as a ready-to-use coating for in-house application or as pre-coated film for streamlined supply chain integration.

Empowering the Packaging Value Chain

Converters: Turnkey path to recyclable, high-barrier structures without costly retooling.
Brand owners: Supports goals for 100% recyclable packaging and lower carbon footprint while extending shelf life.
Consumers: Benefit from safer, more sustainable packaging.

About CelluForce: Founded in 2010, CelluForce is the global leader in CNC and formulated CNC product development, production, and commercialization. Operating the world’s largest CNC plant, CelluForce supplies CNC for various industrial applications. Shareholders include Domtar, FPInnovations, SLB, Suzano, and Investissement Québec.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250922865839/en/

Contacts

Samples and technical information: sales@celluforce.com | +1-514-360-1023
Website:www.celluforce.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.celluforce.
com%2F&esheet=54327064&newsitemid=20250922865839&lan=en-US&anchor=www.celluforce
.com&index=1&md5=15e1c54fb461ddbbe2b3c58700e52537
Media Contact: Sébastien Corbeil, President & CEO

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press Release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechnology executive, bringing over two decades of therapeutic and diagnostic R&D experience within industry to Mosaic Therapeutics, with a track record spanning from IND through to NDA/BLA/MAA approval. Most recently he served at BioXcel Therapeutics as EVP, Head of Product Developme

The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press Release

The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions. “Through our work we increasingly s

Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 08:00:00 CEST | Press Release

As millions of Europeans2 get ready to enjoy the Easter weekend, new research from Samsung finds Europe’s public spaces have become shared screens: 56% of people say they have accidentally looked at a stranger’s phone, citing public transport as the most likely place to notice someone else’s screen (57%). Nearly one in four Europeans2 (24%) admit to looking at someone else’s phone out of curiosity, exposing a stream of private content from personal photos to bank details. Samsung Electronics surveyed 11,000 Europeans2 to support the launch of the Galaxy S26 Ultra, which introduces a built-in Privacy Display. This new hardware-based technology keeps screen content visible only from the front to protect privacy from side angles, without compromising the viewing experience3. The study further reveals a gap between perceived phone privacy and reality: While 48%* feel their own phone use is private when using it in crowded places, 52%** find it easy to view someone else’s screen in public.

RevolKa Reimagines Antibody Engineering with "RevoAb ® "1.4.2026 06:30:00 CEST | Press Release

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allows researchers worldwide to experience RevolKa’s high-performance antibody design. Key Advantages of RevoAb® Speed: Multiple optimi

Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press Release

NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales, reshaping channel strategies 49% of consumers are willing to pay more for locally made products, ref

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom